|
|
||||||||
1 Department of Psychiatry and
Behavioral Sciences, Adult
Otsuka Long-Evans Tokushima fatty (OLETF) rats lack functional
cholecystokinin A (CCK-A) receptors, are diabetic, hyperphagic, and
obese, and have patterns of ingestion consistent with a satiety deficit
secondary to CCK insensitivity. Because dietary fat potently stimulates
CCK release, we examined how dietary fat modulates feeding in adult
male OLETF rats and their lean [Long-Evans Tokushima (LETO)] controls. High-fat feeding produced
sustained overconsumption of high-fat diet (30% corn oil in powdered
chow) over a 3-wk period in OLETF but not LETO rats. We then assessed
the ability of gastric gavage (5 ml, 1-2 kcal/ml × 15 s) or
duodenal preloads (1 kcal/ml, 0.44 ml/min × 10 min) of
liquid carbohydrate (glucose), protein (peptone), or fat (Intralipid)
to suppress subsequent 30-min 12.5% glucose intake in both strains. In
OLETF rats, gastric and duodenal fat preloads were significantly less
effective in suppressing subsequent intake than were equicaloric
peptone or glucose. These results demonstrate that OLETF rats fail to
compensate for fat calories and suggest that their hyperphagia and
obesity may stem from a reduced ability to process nutrient-elicited
gastrointestinal satiety signals.
energy homeostasis; food intake; non-insulin-dependent diabetes
mellitus; obesity; brain-gut communication
THE PRESENCE OF NUTRIENTS in the gastrointestinal tract
has been shown to suppress real and sham feeding in a range of species. Food in the gut has mechanical, nutrient chemical, and secretagogue properties that may elicit negative feedback signals critical in the
control of food intake. For example, CCK is a gut-brain peptide
released by the presence of nutrients in the duodenum, and an important
role for CCK in the negative feedback control of ingestion has been
demonstrated. Exogenous peripheral administration of CCK suppresses
food intake (13), and this inhibition is mediated by interactions of
CCK with the CCK-A receptor subtype; CCK-A antagonists block the
satiety actions of exogenous CCK and can stimulate feeding when
administered alone (13, 20). Furthermore, the ability of
duodenal nutrient infusions to suppress food intake may be attenuated
or blocked by CCK-A antagonists (31), supporting a causal linkage
between nutrient-elicited release of CCK acting at CCK-A receptors and
duodenal nutrient-induced suppression of food intake.
Otsuka Long-Evans Tokushima fatty (OLETF) rats are an outbred strain of
Long-Evans rat that congenitally lacks a 6-kb segment including the
promoter region of the gene encoding for the CCK-A receptor (25),
resulting in a failure to produce or express functional CCK-A receptors
(7). OLETF rats are hyperphagic, become obese, and develop
noninsulin-dependent diabetes mellitus (NIDDM) (10). We have previously
demonstrated that OLETF hyperphagia is characterized by increased meal
size (15), consistent with the interpretation that the lack of CCK-A
receptors results in a satiety deficit that promotes the hyperphagia
and obesity observed in this phenotype. OLETF rats represent a unique
model wherein a clearly identified genetic deficit in a meal-related
satiety-signaling pathway may contribute to the dysregulation of energy
balance over the life span, as expressed by obesity.
The present experiments were designed to further evaluate the
relationships among the OLETF rats' deficient CCK signaling pathway,
OLETF hyperphagia, and obesity. Specifically, we examined the ability
of dietary fat, a macronutrient CCK secretagogue, to modulate food
intake and energy balance in OLETF rats in two paradigms. In the first,
daily food intake and body weight were compared throughout a 3-wk
period in which OLETF and Long-Evans Tokushima (LETO) rats were
maintained on powdered chow or a high-fat semisolid diet. In the
second, we compared the ability of gastric and duodenal preloads of
equicaloric fat, carbohydrate, and protein solutions to suppress
subsequent liquid glucose intake in LETO and OLETF rats.
Male OLETF and LETO rats, obtained as a generous gift from the
Tokushima Research Institute, Otsuka Pharmaceutical Tokushima, Japan,
served as subjects in all studies. Rats were 4-5 wk old when they
arrived in our laboratory. On arrival, there were no differences in the
body weight between the two groups. Rats were individually housed in
hanging wire mesh cages maintained on a 12:12-h light-dark cycle
(lights on at 7:00 AM), and for the initial 2 wk in the laboratory,
rats were maintained with ad libitum access to pelleted Purina chow and water.
Responses to high-fat feeding. Twenty
male OLETF and twenty-one male LETO rats were used in these
experiments. Rats were maintained on daily ad libitum pelleted Purina
chow until their body weight curves began to reach asymptotic levels
(25 wk). At this time, tail vein blood (2 × 300 µl) was drawn
twice on a single day, at 0700 and 1900, and spun in a microcentrifuge
(10,000 rpm × 7 min), and plasma was extracted and frozen at
Data analysis. Plasma leptin, glucose,
and insulin values obtained before 3 wk high-fat feeding were analyzed
by two-way mixed-model ANOVA with strain and time of day (0700 vs.
1900) as factors. Significant differences
(P < 0.05) among individual strain × time pairs were assessed with planned
t comparisons, employing the pooled
error term from the ANOVA. Carcass fat content and plasma glucose
determinations after high-fat feeding were analyzed by two-way ANOVA
with strain (OLETF vs. LETO) and maintenance diet (low vs. high fat) as
factors. Significant differences (P < 0.05) among individual strain × diet pairs were assessed with
planned t comparisons, employing the
pooled error term from the ANOVA. Daily food intake (in grams) and
daily calories consumed throughout the 3-wk diet regimen were analyzed
with three-way mixed-model ANOVA with strain, day, and diet as factors.
Significant differences (P < 0.05)
among individual strain × diet pairs were assessed with planned
t comparisons, employing the pooled
error term from the ANOVA. Body weight gain across the 3-wk diet period
was analyzed with two-way ANOVA with strain and diet as factors.
Effects of gastric nutrient preloads on subsequent
food intake. Seven LETO and six OLETF rats, aged 12 wk
at the beginning of the study, were trained for 1 wk to consume liquid
Ensure (Ross Laboratories, 1 kcal/ml) as their maintenance diet,
available from 1200 until 1700 daily, with tap water available ad
libitum. Both LETO and OLETF rats maintained their pretesting body
weight throughout this feeding regimen. Pretesting body weight averages ± SE for each group were: LETO, 289.8 ± 8.4 g; OLETF, 393.3 ± 9.0 g. Rats were handled daily and adapted to receiving a 5-Fr stainless steel oral gavage tube for a 15-s period each morning, 5 min
before 30-min access to 12.5% glucose liquid diet as an intake test.
On weekdays, rats received one intake test per day. Tests began at 1000 and were completed by 1200. A test consisted of a 5 ml/10 s gastric
gavage preload followed 5 min later by 30-min access to 12.5% glucose.
Glucose intake (in milliliters) was measured at 30 min. Gastric
preloads of warm (37°C) glucose, peptone (Sigma, type II, from
meat), and Intralipid (10%, 1.1 kcal/ml; 20%, 2.0 kcal/ml;
Kabi-Vitrum) were delivered at each of two caloric concentrations, 1 and 2 kcal/ml, randomly across days. Distilled water was the solvent
for glucose and peptone solutions, and physiological saline was used to
dilute 10% Intralipid to 1.0 kcal/ml. All rats received the same type
of preload on a given day, and at least one physiological saline
preload day always intervened between two nutrient preload days.
Data analysis. Because 5-ml
physiological saline preloads failed to differ significantly from no
preload or control gavage conditions
[F(2,25) = 1.3, P > 0.3, data not shown],
12.5% glucose intake data were expressed as percentage suppression
below the average baseline saline preload condition for the trials
preceding and after each macronutrient preload trial. Three-way
mixed-model ANOVA with strain, macronutrient, and caloric concentration
was performed. Significant differences
(P < 0.05) among individual strain × caloric concentration and strain × macronutrient × caloric concentration pairs were assessed with planned
t comparisons, employing the pooled
error terms from the ANOVAs.
Effects of duodenal nutrient preloads on subsequent
food intake. In Male LETO and OLETF rats
(n = 6/strain), we evaluated the
feeding inhibitory effects of duodenal macronutrient preloads. Before
surgery all rats were trained for 1 wk to consume liquid Ensure (Ross
Laboratories, 1 kcal/ml) as their maintenance diet, available from 1200 until 1700 daily, with tap water available ad libitum. Both LETO and
OLETF rats maintained their pretesting body weight throughout this
feeding regimen. Pretesting body weight averages ± SE for each
group were: LETO, 401 ± 14.5 g; OLETF, 518 ± 11.2 g. Rats were
handled daily and adapted to the morning intake test protocol as
follows. They were placed individually in a wire cage next to an
infusion pump, and the pump was turned on for 10 min before each rat
was returned to its home cage and given 30-min access to 12.5% glucose
solution. All rats adapted well to this procedure and, by
the end of the 1-wk training period, consumed at least 10 ml of glucose
during the 30-min morning access period.
Duodenal cannulation surgery. After
training, rats were deprived of food but not water overnight before
surgery. Rats were anesthetized with a mixture of ketamine (Vetalar,
100 mg/ml) and xylazine (Rompun, 20 mg/ml) (4:3, 0.1 ml/100 g body wt)
to maintain a surgical level of anesthesia. A laparotomy incision was
made on the ventral flank, and the proximal 1.5 cm of the duodenum was
exposed and kept warm and moist with saline-soaked sterile cotton
gauze. A 25-gauge needle was used to make a small puncture wound on the
ventral aspect of the duodenum in a region where the vascular arcade
was as sparse as possible to minimize bleeding. Small-diameter Silastic
tubing (0.012 in. ID, 0.025 in. OD) with a blunted tip was
inserted 2 cm into the puncture wound in an anad
direction, such that the tip rested ~3.5 cm anad to the pyloric sphincter. The cannula was anchored to the outer serosal surface of the
proximal duodenum around the puncture wound with a drop of cyanoacrylic
cement (Vetbond) and a 0.5-cm2
piece of Marlex mesh sewn to the serosal surface with 6-0 silk suture.
The proximal portion of the cannula exited to the abdominal cavity
through another small puncture wound in the right lateral abdominal
wall, and this proximal portion of the duodenal cannula was then drawn
subcutaneously to exit from a 2-cm midline incision on the skin of the
back of the neck, just rostral to the interscapular area. The abdominal
wall incision was closed with 4-0 silk, and the skin incision was
closed with stainless steel wound clips. The exteriorized portion of
the duodenal cannula was anchored to the ventral neck musculature with
Marlex mesh sutured in place with 4-0 silk suture. The mesh was bound
to the Silastic tubing with silicone adhesive, and the duodenal cannula
tubing was pressure fitted to a 2.5-cm length of larger diameter (0.025 in. ID, 0.05 in. OD) exteriorized Silastic tubing. The
neck skin incision was closed with cyanoacrylic cement (Vetbond). A
2-cm length of blunted 23-gauge stainless steel tubing, pressure fitted
into the larger Silastic tubing, served as an obturator to block the
duodenal cannula when it was not in use. All rats received 10,000 U
ampicillin intramuscularly on the day of and 2 days after surgery. All
rats recovered their presurgical body weights within 4-6 days of
surgery. Intake tests were begun 10 days after the completion of
duodenal cannula surgeries.
Duodenal preload intake tests. On
weekdays, rats received one intake test per day. Tests began at 1000 and were completed by 1200. A test consisted of a 0.44 ml/min × 10 min duodenal preload delivered by a syringe pump followed
immediately by 30-min access to 12.5% glucose. Diet intake (in
milliliters) was measured at 30 min. Duodenal preloads of glucose,
peptone (Sigma; type II, from meat) and Intralipid (10%, 1.1 kcal/ml;
Kabi-Vitrum) were delivered at 1 kcal/ml randomly across days. All
duodenal infusates were warmed to 37°C before infusion. Distilled
water was the solvent for glucose and peptone solutions, and
physiological saline was used to dilute 10% Intralipid to 1.0 kcal/ml.
The infusion rate and caloric concentration were chosen based on values
of Walls et al. (27) used to suppress food intake after duodenal
nutrient infusions. All rats received the same type of preload on a
given day, and a physiological saline preload day always intervened between two successive nutrient preload days.
Duodenal cannula verification. At the
end of experiments, rats were reanesthetized as above, 0.3 ml of a 1%
fast green dye solution was slowly infused into the duodenal cannula,
and the laparotomy incision was reexposed to reveal the
gastrointestinal spread of duodenal cannula infusates. In all cases,
the dye was localized to points including and distal to the proximal 2 cm of the duodenum and did not appear in the stomach at all.
Data analysis. Because intake data
after 4.4 ml/10 min physiological saline duodenal preloads failed to
differ significantly from no preload condition
[F(2,23) = 0.83, P > 0.5, data not shown], glucose intake data were expressed as percentage suppression below the
average baseline saline preload condition for the trials preceding and
after each macronutrient preload trial. Data were analyzed by two-way
repeated-measures ANOVA with strain and macronutrient as factors.
Significant differences (P < 0.05)
among individual strain × preload pairs were assessed with
planned t comparisons, employing the
pooled error term from the ANOVAs.
Table 1 summarizes the body weights that
OLETF and LETO rats maintained on standard Purina chow before the
high-fat feeding regimen began. At this time, OLETF rats were
significantly larger then LETO rats
[F(1,18) = 32.5, P < 0.001]. As shown in Fig.
1, OLETF rats were hyperglycemic
[F(1,18) = 10.0, P < 0.005] and hyperleptinemic
[F(1,18) = 4.5, P < 0.04] compared with LETO
controls (Fig 1). There was no significant
effect of sample time [0700 vs. 1900; glucose:
F(1,18) = 2.85, P > 0.1; leptin:
F(1,18) = 2.0, P > 0.15] nor a significant
strain × sample time interaction for either plasma glucose or
plasma leptin [glucose:
F(1,18) = 0.110, P > 0.3; leptin:
F(1,18) = 0.967, P > 0.3], indicating that the
hyperglycemia and hyperleptinemia in OLETF rats relative to LETO rats
tended to be stable across these sampling times. OLETF rats also showed
a trend toward hyperinsulinemia relative to LETO controls, but this was
not significant (P < 0.2).
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
20°C for subsequent determinations of plasma leptin,
glucose, and insulin levels from 11 OLETF and 9 LETO rats. Plasma
glucose was measured with a YSI glucose analyzer (YSI Instruments,
Yellow Springs, OH), and both plasma insulin and leptin were determined
with rat-sensitive radioimmunoassay kits (Linco). Rats were then
maintained for 1 wk on powdered Purina chow to familiarize them with
this form of the diet. Ten OLETF and ten LETO rats continued to be
maintained ad libitum on standard powdered Purina Rat Chow diet (3.8 kcal/g), whereas 10 OLETF and 11 LETO rats were switched to a high-fat
diet (powdered Purina chow mixed with Mazola corn oil, 30% by weight,
5.4 kcal/g). Daily food intake and body weight were measured for 3 wk.
Rats were then euthanized, all epididymal white fat and interscapular
brown fat were harvested and weighed, and tail blood was obtained for plasma glucose determinations as above. Determination of body fat in
the remaining carcass was performed in accordance with the ether
extraction method of Bell and Stern (1). Briefly, carcasses were
freeze-dried and ground in a Wiley mill, triplicate 1-g samples were
taken, and fat was extracted with ether until asymptotic weight was
achieved (~4 h). The ether was evaporated, and the weight of the
remaining extract was expressed as a percentage of the initial 1-g
dried sample.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
Table 1.
Initial weights of LETO and OLETF rats before 3-wk access to
powdered Purina chow with or without 30% corn oil and weight
gain following 3-wk diet access

View larger version (14K):
[in a new window]
Fig. 1.
Plasma glucose, insulin, and leptin in ad libitum chow-fed OLETF and
LETO rats 27-30 wk of age before dietary fat regimen, sampled at
0700 and 1900 on same day. Data are expressed as means ± SE. OLETF rats were significantly more hyperglycemic and
hyperleptinemic than LETO controls, and trended toward hyperinsulinemia
as well. * Significantly different from LETO control
(P < 0.05).
Table 1 also shows the body weight gain of OLETF and LETO rats after 3 wk diet maintenance with powdered Purina chow or high-fat diet (powdered chow contained 30% corn oil by weight). There was a significant overall effect of diet regimen on body weight gain over the 3-wk period [F(1,18) = 18.1, P < 0.001]. Specifically, OLETF but not LETO rats gained significantly greater amounts of weight under high-fat feeding compared with their respective chow diet-fed controls [OLETF: F(1,18) = 16.4, P < 0.03; LETO: F(1,18) = 3.8, P < 0.064].
Figure 2,
top, shows the daily food intake (in
grams) for both groups of rats under the two dietary conditions. There
was an overall significant effect of diet on grams consumed
[F(1,37) = 6.98, P < 0.01]. LETO rats consumed
significantly fewer grams of high-fat chow than those maintained on
chow throughout the 3-wk period
[F(1,37) = 15.04, P < 0.001]. Thus LETO rats
reduced their food intake in response to the high caloric content of
the high-fat diet. In contrast, OLETF rats maintained on high-fat chow
did not differ in their daily gram intake compared with OLETF maintained on chow diet [F(1,37) = 0.009, P > 0.9].
|
Figure 2, bottom, shows daily food intake in calories for both groups of rats under the two dietary conditions. There was an overall significant effect of diet on calories consumed [F(1,37) = 97, P < 0.001], where high-fat diet promoted more caloric intake than did chow diets. Both LETO and OLETF rats on high-fat chow consumed more calories than their counterparts maintained on chow diet [LETO: F(1,37) = 67.1, P < 0.001; OLETF: F(1,37) = 32.6, P < 0.001]. Planned t comparisons revealed that this effect was maintained throughout the 3-wk period in OLETF rats (P < 0.05), whereas it was absent after day 8 in LETO rats (P > 0.1). Thus LETO rats maintained on high-fat diets demonstrated complete caloric compensation for the more nutrient-dense high-fat diet within a week, whereas OLETF rats continued to overconsume high-fat diet across the 3-wk period compared with chow-fed OLETF rats.
Figure 3 summarizes the plasma glucose and
body fat analyses from the LETO and OLETF rats after the 3-wk high fat
vs. chow dietary regimen. OLETF rats were hyperglycemic relative to
LETO controls [F(1,18) = 27.9, P < 0.001], and
there was no significant diet × strain interaction
(P > 0.3). OLETF rats had
significantly more carcass fat than did LETO rats
[F(1,19) = 10.97, P < 0.004], and high-fat
feeding caused significant increases in carcass fat in both strains
[F(1,19) = 52.5, P < 0.001]. OLETF rats also
had significantly more white epididymal fat than did LETO controls [F(1,19) = 13.3, P < 0.05], and high-fat
feeding caused significant increases in carcass fat in both strains
[F(1,19) = 12.7, P < 0.002]. OLETF rats fed
high-fat diets had significantly higher interscapular brown fat than
did chow-fed OLETF rats [F(1,19) = 4.6, P < 0.04], who did not
differ from LETO rats (P > 0.1).
|
Effects of gastric nutrient preloads.
The feeding inhibitory effects of gastric nutrient preloads are shown
in Fig. 4. There was a significant overall
effect of caloric content
[F(1,11) = 37.2, P < 0.01]; overall, the
10-kcal loads suppressed intake to a greater degree than did the 5-kcal
loads. In LETO rats, increasing caloric concentrations of glucose,
peptone, and Intralipid gastric preloads dose-dependently suppressed
subsequent 30-min glucose intake (P < 0.05). Also, for LETO rats, there was no simple effect of nutrient
on the degree of suppression
[F(2,22) = 0.344, P > 0.5]; i.e., within a
caloric concentration across the three macronutrients, glucose,
peptone, and Intralipid produced statistically similar levels of intake
suppression in LETO rats.
|
In OLETF rats, the profile for feeding suppression after gastric glucose and peptone preloads was similar to that of LETO rats, where there was a dose-dependent increase in the degree of suppression with increasing preload concentration [F(1,6) = 8.54, P < 0.01]. However, there was a significant simple effect of nutrient in OLETF rats [F(2,22) = 6,74, P < 0.01]. Specifically, gastric Intralipid was significantly less effective than equicaloric glucose and peptone at the 10-kcal load (P < 0.05).
Within-concentration comparisons for a single macronutrient preload type revealed that glucose and peptone preloads suppressed intake to similar degrees in both OLETF and LETO rats. (P > 0.9). In contrast, Intralipid gastric preloads were much less effective in suppressing food intake in OLETF rats than in LETO controls at the high (10 kcal/5 ml; P < 0.01) but not at the low (5 kcal/5 ml) concentration (P > 0.5).
Effects of duodenal nutrient preloads.
The feeding- inhibitory effects of 1 kcal/ml × 10 ml duodenal
macronutrient preloads are shown in Fig. 5.
Duodenal preloads produced significantly less intake suppression in
OLETF rats than in LETO controls
[F(1,10) = 9.71, P < 0.01]. There was also a
significant overall effect of nutrient
[F(2,20) = 6.04, P < 0.01]. Duodenal fat was
significantly less effective in suppressing intake than was glucose or
peptone in OLETF [F(2,20) = 3.48, P < 0.05] but not in
LETO rats [F(2,20)= 2.63, P > 0.09].
|
| |
DISCUSSION |
|---|
|
|
|---|
Overall, OLETF rats maintained on a standard chow diet 1) weighed significantly more, 2) had more white adipose tissue and carcass fat, and 3) were hyperglycemic and hyperleptinemic and tended toward hyperinsulinemia relative to LETO controls. This profile is consistent with previous results characterizing the obese and diabetic features of the adult OLETF rat at comparable ages (27-35 wk) (29). We and others (12) have previously suggested that the obesity seen in the OLETF rat is at least in part caused by increased ingestive behavior; OLETF rats are hyperphagic, and this hyperphagia is manifested as an increase in the meal size rather than meal frequency (15). We suggest that the increased meal size is consistent with a lack of meal-elicited CCK satiety signals due to the absence of functional CCK-A receptors in OLETF rats (15). The hyperglycemia and hyperleptinemia seen in obese OLETF rats are likely secondary to the increase in body weight; OLETF rats given the opportunity to exercise on a running wheel do not become obese, and have plasma glucose and total body fat that do not significantly differ from LETO controls (23).
The current findings reveal that OLETF rats lacking CCK-A receptors have decreased responsiveness to dietary fat. OLETF rats persistently overconsumed a high-fat diet throughout a 3-wk access period and failed to compensate for the extra energy provided by this calorically dense diet. LETO rats maintained on a high-fat diet initially consumed greater numbers of calories of the diet compared with controls maintained on standard chow, but they began to compensate for the increased caloric density immediately, and by day 8 of the 3-wk trial their caloric intake on high-fat and chow diets did not differ. Although there was a trend for fat diet-fed LETO rats to gain more weight than chow-fed controls, this did not reach statistical significance. In contrast, OLETF rats consistently consumed more calories on the high-fat diet, resulting in significantly greater body weight gain and body fat accumulation. This persistent overconsumption of a high-fat diet is similar to the fa/fa Zucker fatty rat, which has a deficit in the leptin receptor (18). When given access to a high-fat diet, Zucker rats fail to compensate for the increased caloric density, and their caloric intake remains elevated for up to 7 wk (26). Adipose mass also increases over this period, and it has been suggested that there is a causal relationship between increased fat deposition and the gradual decrease in overconsumption of high-fat diets in Zucker fa/fa rats (26). Osborne-Mendel rats, another obesity-prone rat strain, also overconsume high-fat diets, resulting in significant weight gain and fat deposition (30).
At death, high-fat fed OLETF rats had significantly greater percent dry carcass fat and interscapular brown adipose tissue compared with high-fat-diet fed LETO controls and chow-fed OLETF controls. High-fat feeding has been shown to increase brown adipose tissue (BAT) mass but also to increase sympathetic activity and BAT activity relative to chow-fed controls (21). However, Osborne-Mendel rats fed a high-fat diet have lower BAT norepinephrine turnover, an index of reduced sympathetic activity, despite increased BAT mass (30). The increased brown fat mass after high-fat feeding in OLETF rats may also be a result of reduced sympathetic activation.
In short-term intake tests, OLETF rats also revealed a reduced responsiveness to dietary fats. The feeding-suppressive actions of gastric nutrient preloads were remarkably similar for LETO and OLETF rats, with one exception: the 2-kcal/ml gastric Intralipid preload was significantly less effective in suppressing food intake in OLETF rats compared with LETO controls. Duodenal lipid infusions were also particularly ineffective in suppressing food intake in OLETF rats compared with 1) equicaloric carbohydrate and protein in OLETF rats and 2) duodenal lipid in LETO controls. Duodenal fat is a potent secretagogue of CCK in rats (2, 9). Duodenal lipids have previously been shown to suppress feeding (8, 27), and CCK-A receptor antagonists reverse this suppression (28, 31). The relative inability of gastric and duodenal lipid to suppress feeding in OLETF rats is consistent with the inability of lipid-induced CCK release to provide CCK-A receptor-mediated negative feedback signals important in the control of food intake.
The ability of duodenal carbohydrate and protein solutions to suppress intake was also significantly suppressed in OLETF rats relative to LETO controls, although to a lesser degree than that of fat. The ability of some duodenal protein and carbohydrate solutions to slow gastric emptying and suppress food intake has been demonstrated to depend on endogenous, nutrient-elicited CCK acting at CCK-A receptors. In the rat, the inhibition of gastric emptying produced by duodenal peptone and maltose solutions is reversed by the potent and specific CCK-A receptor antagonist devazepide (5, 19). In rhesus monkeys and humans, devazepide has been demonstrated to accelerate glucose gastric emptying (6, 14). In addition, Yox et al. (31) have shown that the suppression of feeding produced by intraintestinal maltose infusions is blocked by devazepide. The present attenuation of the feeding suppressive effects of duodenal carbohydrate and protein solutions is consistent with the lack of a functional CCK-A receptor-mediated negative feedback pathway in OLETF rats.
Perspectives
We have interpreted the hyperphagia and increased meal size in OLETF rats as reflecting a deficit in the ability to detect satiety signals provided by endogenous, meal-elicited CCK. The present data extend this interpretive framework by demonstrating that nutrient secretagogues of CCK, particularly lipid, are significantly less effective in suppressing food intake. From a mechanistic perspective, we view the present reduced responsiveness to dietary fat in OLETF as secondary to the deficit in the CCK signaling pathways in OLETF rats: the lack of functional CCK-A receptors. Both CCK and duodenal nutrient-induced satiety are mediated by a common neural substrate: the afferent subdiaphragmatic vagus nerve. CCK-A receptors have been localized to subdiaphragmatic vagal afferent fibers (3, 11, 16, 17), CCK stimulates gut vagal afferents (4, 22), and afferent subdiaphragmatic vagotomy blocks the satiety actions of low doses of peripherally administered CCK (24). Similarly, subdiaphragmatic vagal deafferentation of the duodenum attenuates or blocks the ability of duodenal nutrients to suppress food intake (27). Interpreted in the context of the CCK-A receptor mediation of CCK satiety, the current data underscore a critical role for endogenous CCK acting at vagal CCK-A receptors in the feeding suppressive actions of nutrients in the gut. These data also support the view that a chronic deficit in meal-elicited CCKergic negative feedback signals can promote obesity.| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-19302, a grant from the Maryland Agricultural Experimental Station (to T. W. Castonguay), and the generous gift of the OLETF and LETO rats from the Tokushima Research Institute, Otsuka Pharmaceuticals.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: G. J. Schwartz, 720 Rutland Ave., Ross room 618, Baltimore, MD 21205-2196 (E-mail: gjs{at}jhmi.edu).
Received 26 February 1999; accepted in final form 17 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bell, G. E.,
and
J. F. Stern.
Evaluation of body composition of young obese and lean zucker rats.
Growth
41:
63-80,
1977[Medline].
2.
Brenner, L.,
D. P. Yox,
and
R. C. Ritter.
Suppression of sham feeding by intraintestinal nutrients is not correlated with plasma cholecystokinin elevation.
Am. J. Physiol.
264 (Regulatory Integrative Comp. Physiol. 33):
R972-R976,
1993
3.
Corp, E. S.,
J. McQuade,
T. H. Moran,
and
G. P. Smith.
Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
Brain Res.
623:
161-166,
1993[Medline].
4.
Davison, J. S.,
and
G. D. Clarke.
Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors
Am. J. Physiol.
255 (Gastrointest. Liver Physiol. 18):
G55-G61,
1988
5.
Forster, E. R.,
T. Green,
M. Elliot,
A. Bremner,
and
G. J. Dockray.
Gastric emptying in rats: role of afferent neurons and cholecystokinin.
Am. J. Physiol.
258 (Gastrointest. Liver Physiol. 21):
G552-G556,
1990
6.
Fried, M.,
U. Erlacher,
W. Schwizer,
C. Lochner,
J. Koerer,
C. Beglinger,
J. B. Jansen,
C. B. Lamers,
F. Harder,
A. Bishof-Delaloye,
G. A. Stadler,
and
L. Rovati.
Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans.
Gastroenterology
101:
503-511,
1991[Medline].
7.
Funakoshi, A.,
K. Miyasaka,
H. Shinozaki,
M. Masuda,
T. Kawanami,
Y. Takata,
and
A. Komo.
An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
Biochem. Biophys. Res. Commun.
210:
787-796,
1995[Medline].
8.
Greenberg, D.,
G. P. Smith,
and
J. Gibbs.
Intraduodenal infusions of fat elicit satiety in sham-feeding rats.
Am. J. Physiol.
59 (Regulatory Integrative Comp. Physiol. 28):
R110-R118,
1990.
9.
Hölzer, H.,
C. M. Turkelson,
T. E. Solomon,
and
H. E. Raybould.
Intestinal lipid inhibits gastric emptying via CCK and vagal capsaicin-sensitive afferent pathway in rats.
Am. J. Physiol.
267 (Gastrointest. Liver Physiol. 30):
G625-G629,
1994
10.
Kawano, K.,
T. Hirashima,
S. Mori,
Y. Saitoh,
M. Kurosumi,
and
T. Natori.
Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain.
Diabetes
41:
1422-1428,
1992[Abstract].
11.
Mercer, J. G.,
and
C. B. Lawrence.
Selectivity of cholecystokinin receptor antagonists, MK-329 and L-365,260 for axonally transported CCK binding sites in the rat vagus nerve.
Neurosci. Lett.
137:
229-231,
1992[Medline].
12.
Miyasaka, K.,
S. Kanai,
M. Ohta,
T. Kawanami,
A. Kono,
and
A. Funakoshi.
Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene.
Neurosci. Lett.
180:
143-146,
1994[Medline].
13.
Moran, T. H.,
P. J. Ameglio,
G. J. Schwartz,
and
P. R. McHugh.
Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK.
Am. J. Physiol.
262 (Regulatory Integrative Comp. Physiol. 31):
R46-R50,
1992
14.
Moran, T. H.,
D. G. Field,
S. Knipp,
T. S. Carrigan,
and
G. J. Schwartz.
Endogenous CCK in the control of gastric emptying of glucose and maltose.
Peptides
18:
547-550,
1997[Medline].
15.
Moran, T. H.,
L. F. Katz,
C. Plata-Salaman,
and
G. J. Schwartz.
Disordered food intake and obesity in rats lacking cholecystokinin A receptors.
Am. J. Physiol.
274 (Regulatory Integrative Comp. Physiol. 43):
R618-R625,
1998
16.
Moran, T. H.,
R. Norgren,
R. J. Crosby,
and
P. R. McHugh.
Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.
Brain Res.
526:
95-102,
1990[Medline].
17.
Moran, T. H.,
G. P. Smith,
A. M. Hostetler,
and
P. R. McHugh.
Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches.
Brain Res.
415:
149-152,
1987[Medline].
18.
Phillips, M. S.,
Q. Liu,
H. A. Hammond,
V. Dugan,
P. J. Hey,
C. J. Casey,
and
J. F. Hess.
Leptin receptor missense mutation in the fatty Zucker rat.
Nat. Genet.
13:
18-19,
1996[Medline].
19.
Raybould, H. E.,
and
H. Hölzer.
Dual capsaicin-sensitive pathways mediate inhibition of gastric emptying in rat induced by intestinal carbohydrate.
Neurosci. Lett.
141:
236-238,
1992[Medline].
20.
Reidelberger, R. D.,
and
M. F. O'Rourke.
Potent cholecystokinin antagonist L-364,718 stimulates food intake in rats.
Am. J. Physiol.
257 (Regulatory Integrative Comp. Physiol. 26):
R1512-R1518,
1989
21.
Rothwell, N. J.,
M. J. Stock,
and
B. P. Warwick.
Energy balance and brown fat activity in rats fed cafeteria diets of high-fat, semisynthetic diets at several levels of intake.
Metabolism
34:
474-480,
1985[Medline].
22.
Schwartz, G. J.,
P. R. McHugh,
and
T. H. Moran.
Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents.
Am. J. Physiol.
265 (Regulatory Integrative Comp. Physiol. 34):
R872-R876,
1993
23.
Shima, K.,
K. Shi,
T. Sano,
T. Iwami,
A. Mizuno,
and
Y. Noma.
Is exercise training effective in preventing diabetes mellitus in the Otsuka-Long-Evans-Tokushima fatty rat, a model of spontaneous non-insulin dependent diabetes mellitus?
Metabolism
42:
971-977,
1993[Medline].
24.
Smith, G. P.,
C. Jerome,
and
R. Norgren.
Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats.
Am. J. Physiol.
249 (Regulatory Integrative Comp. Physiol. 18):
R638-R641,
1985
25.
Takiguchi, S.,
Y. Takata,
A. Funakoshi,
K. Miyasaka,
K. Kataoka,
Y. Fujimura,
T. Goto,
and
A. Kono.
Disrupted cholecystokinin type-A receptor (CCK-AR) gene in OLETF rats.
Gene
197:
169-175,
1997[Medline].
26.
Vasselli, J. R.,
J. A. Fiene,
and
C. A. Maggio.
Relationship of adipocyte size to hyperphagia in developing male obese Zucker rats.
Am. J. Physiol.
262 (Regulatory Integrative Comp. Physiol. 31):
R33-R38,
1992
27.
Walls, E. K.,
R. J. Phillips,
F. B. Wang,
M.-C. Holst,
and
T. L. Powley.
Suppression of meal size by intestinal nutrients is eliminated by celiac vagal deafferentation.
Am. J. Physiol.
269 (Regulatory Integrative Comp. Physiol. 38):
R1410-R1419,
1995
28.
Woltman, T.,
D. Castellanos,
and
R. Reidelberger.
Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats.
Am. J. Physiol.
269 (Regulatory Integrative Comp. Physiol. 38):
R1420-R1433,
1995
29.
Yagi, K.,
S. Kim,
H. Wanibuchi,
T. Yamashita,
Y. Yamamura,
and
H. Iwao.
Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima fatty rats.
Hypertension
29:
728-735,
1997
30.
Yoshida, T.,
J. S. Fisler,
M. Fukushima,
G. A. Bray,
and
R. A. Schemmel.
Diet, lighting, and food intake affect norepinephrine turnover in dietary obesity.
Am. J. Physiol.
252 (Regulatory Integrative Comp. Physiol. 21):
R402-R408,
1987
31.
Yox, D. P.,
L. Brenner,
and
R. C. Ritter.
CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients.
Am. J. Physiol.
262 (Regulatory Integrative Comp. Physiol. 31):
R554-R561,
1992
This article has been cited by other articles:
![]() |
S. Bi, J. Chen, R. R. Behles, J. Hyun, A. S. Kopin, and T. H. Moran Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R55 - R63. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. De Jonghe, A. Hajnal, and M. Covasa Conditioned preference for sweet stimuli in OLETF rat: effects of food deprivation Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1819 - R1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. De Jonghe, A. Hajnal, and M. Covasa Decreased gastric mechanodetection, but preserved gastric emptying, in CCK-1 receptor-deficient OLETF rats Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G640 - G649. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blumberg, D. Haba, M. Schroeder, G. P. Smith, and A. Weller Independent ingestion and microstructure of feeding patterns in infant rats lacking CCK-1 receptors Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R208 - R218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hajnal, M. Covasa, and N. T. Bello Altered taste sensitivity in obese, prediabetic OLETF rats lacking CCK-1 receptors Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1675 - R1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. De Jonghe, A. Hajnal, and M. Covasa Increased oral and decreased intestinal sensitivity to sucrose in obese, prediabetic CCK-A receptor-deficient OLETF rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R292 - R300. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Moran and K. P. Kinzig Gastrointestinal satiety signals II. Cholecystokinin Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G183 - G188. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, S. R. Thomas, G. Kilroy, G. J. Schwartz, and D. A. York Enterostatin inhibition of dietary fat intake is dependent on CCK-A receptors Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R321 - R328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Glatzle, M. E. Kreis, K. Kawano, H. E. Raybould, and T. T. Zittel Postprandial neuronal activation in the nucleus of the solitary tract is partly mediated by CCK-A receptors Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R222 - R229. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bi, E. E. Ladenheim, G. J. Schwartz, and T. H. Moran A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R254 - R260. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |